Worth reading
22Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Who is moving to which position
Resolved 28 September 2026Incoming appointee
3 itemsScheduled Appointment Date1 October 2026 (TSURUHA HOLDINGS INC.), 16 October 2026 (株式会社ツルハグループマーチャンダイジング)
Kirisawa Hideaki (桐澤 英明)
Previous positionDirector and Executive Officer, responsible for Group Sales and Merchandising; concurrently responsible for ウエルシアHD (株)
New positionDirector and Executive Officer, responsible for Group Sales and Merchandising; concurrently responsible for the Group Pharmacy Operations Division and Head of Pharmacy Operations; concurrently responsible for ウエルシアHD (株)
Nomura Kazuhiko (野村 和彦)
Previous positionExecutive Officer, Head of Pharmacy Operations, responsible for the Group Pharmacy Operations Division
New positionExecutive Officer, Deputy Head of Pharmacy Operations, responsible for the Group Pharmacy Operations Division
Itajima Takayuki (板嶌 貴之)
Previous positionウエルシア薬局(株), attached to the Human Resources Division
New positionLogistics Division, Head of the Logistics Department (seconded to 株式会社ツルハグループマーチャンダイジング)
Departing officer
1 itemChiba Yoshiki (千葉 義樹)Next role stated
Former PositionLogistics Division, Head of the Logistics Department
New position— (attached to the Human Resources Division, ウエルシア薬局(株))
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
| Item | Details |
|---|---|
| Resolution date | 28 September 2026 |
| Scheduled Appointment Date | 1 October 2026 (TSURUHA HOLDINGS INC.), 16 October 2026 (株式会社ツルハグループマーチャンダイジング) |
| Name of appointee | Kirisawa Hideaki (桐澤 英明), Nomura Kazuhiko (野村 和彦), Itajima Takayuki (板嶌 貴之) |
| Appointee's new position | Director and Executive Officer, responsible for Group Sales and Merchandising; concurrently responsible for the Group Pharmacy Operations Division and Head of Pharmacy Operations; concurrently responsible for ウエルシアHD (株), Executive Officer, Deputy Head of Pharmacy Operations, responsible for the Group Pharmacy Operations Division, Logistics Division, Head of the Logistics Department (seconded to 株式会社ツルハグループマーチャンダイジング) |
| Appointee's previous position | Director and Executive Officer, responsible for Group Sales and Merchandising; concurrently responsible for ウエルシアHD (株), Executive Officer, Head of Pharmacy Operations, responsible for the Group Pharmacy Operations Division, ウエルシア薬局(株), attached to the Human Resources Division |
| Name of departing officer | Chiba Yoshiki (千葉 義樹) |
| Former position of departing officer | Logistics Division, Head of the Logistics Department |
| New position of departing officer | — (attached to the Human Resources Division, ウエルシア薬局(株)) |
Items this document does not state (13)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The disclosure states that a resolution was passed to implement personnel changes, but does not specify the reasons for the changes.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.